2015 | PDK1 disruptors and modulators: a patent review | 김승철 | Review |
2017 | Preoperative Assessment of Lymph Node Metastasis in Endometrial Cancer: A Korean Gynecologic Oncology Group Study | 김승철 | Article |
2018 | Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer | 김승철; 주웅; 김윤환 | Article |
2018 | Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer | 김승철; 김윤환 | Article |
2016 | Recent advances in ovarian cancer treatment | 김승철 | Editorial Material |
2019 | Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines | 김승철; 문병인; 허정원; 임우성; 백남선; 정태동 | Article |
2012 | Relationships between distress and symptoms of Hwa-byung in Korean women patients at a cancer center of one university | 김승철; 임원정; 문병인; 주웅; 백남선 | Meeting Abstract |
2019 | Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening | 김승철; 주웅; 김윤환 | Article |
2019 | SPSB1 enhances ovarian cancer cell survival by destabilizing p21 | 김승철; 주웅; 안정혁; 성혜윤; 김윤환; 김현정; 김미경 | Article |
2017 | Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells | 김승철; 주웅; 김윤환; 김현정 | Article |
2017 | Thiol-reducing agents prevent sulforaphane-induced growth inhibition in ovarian cancer cells | 김승철; 권영주 | Article |
2017 | Two-step chromatographic purification of glutathione S-transferase-tagged human papillomavirus type 16 E6 protein and its application for serology | 김승철; 주웅; 김윤환 | Article |
2017 | Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer | 김승철; 주웅; 김윤환 | Article |